The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Utilisation and Safety of Polyethylene Glycol 3350 With Electrolytes in Children Under 2 Years: A Retrospective Cohort
Open accessAbstract
Objectives: In the UK, Movicol paediatric plain (polyethylene glycol 3350 with electrolytes [PEG 3350+E], Norgine, UK), is licensed for chronic constipation in children 2 –11 years of age and faecal impaction (FI) from 5 years. This study aimed to investigate usage and characterise the risk profile in children under 2 years of age using PEG 3350+E in the UK. Methods: Retrospective, single exposure cohort study, with patients identified from Clinical Practice Research Datalink (CPRD) GOLD. Patients first prescribed PEG 3350+E under 2 years of age for the treatment of constipation or FI, between September 2003 and July 2019, were included. Results: There were 13,235 patients with a constipation indication and 40 patients with FI. For the constipation cohort: median age of PEG 3350+E first prescription was 1.2 years [interquartile range (IQR) 0.9, 1.6] and 68.4% had one treatment episode (TE). The mean duration of exposure, in the first TE, was 88.9 days. The most common total daily dose was one sachet (6.9 g). In terms of incident events on treatment, 0.5% of patients had abdominal pain, 3.0% had diarrhoea (may be attributed to treatment) and 4.1% had vomiting. 2.0% had signs/symptoms which could (in extreme cases) be associated with electrolyte disturbance, however, none had abnormal electrolyte values. Discussion: The safety aspect of this study did not identify any signals of concern in the constipation cohort. The number of patients in the FI cohort were too small for robust conclusions. If information were available, then a safety study would ideally assess treatment intake per kilogram, including electrolyte intake, before reaching safety conclusions. Nevertheless, these data contribute to real‐world evidence on the use of PEG 3350+E in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, observational studies corroborate the safety data from RCTs.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of constipation in children and adults: A systematic review
Mugie, S. M., Benninga, M. A., & Lorenzo, C. D. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.12.010 · Cited by 945
Osmotic and stimulant laxatives for the management of childhood constipation
Gordon, M. A., MacDonald, J. K., Parker, C. E., Akobeng, A. K., & Thomas, A. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009118.pub3 · Cited by 218
Voskuijl, W. P., de Lorijn, F., Verwijs, W., Hogeman, P., Heijmans, J., Mäkel, W., Taminiau, J. A. J. M., & Benninga, M. A. (2004) · Gut · doi:10.1136/gut.2004.043620 · Cited by 216
Management of Functional Constipation in Children: Therapy in Practice
Koppen, I. J. N., Lammers, L. A., Benninga, M. A., & Tabbers, M. M. (2015) · Pediatric Drugs · doi:10.1007/s40272-015-0142-4 · Cited by 210
Safety of Polyethylene Glycol 3350 for the Treatment of Chronic Constipation in Children
Pashankar, D. S., Loening-Baucke, V. A., & Bishop, W. P. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.7.661 · Cited by 145
Dupont, C. M., Leluyer, B., Maamri, N., Morali, A., Joye, J., Fiorini, J., Abdelatif, A., Baranes, C., Benoît, S., Benssoussan, A., et al. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000181188.01887.78 · Cited by 140
Gremse, D. A., Hixon, J., & Crutchfield, A. (2002) · Clinical Pediatrics · doi:10.1177/000992280204100405 · Cited by 140
Loening-Baucke, V. A., & Pashankar, D. S. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0220 · Cited by 136
Pashankar, D. S., & Bishop, W. P. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.117002 · Cited by 129
Candy, D. C. A., Edwards, D., & Geraint, M. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000228097.58960.e6 · Cited by 126
Research works printed but not linked: 3
- Candy D, 2016, MOVICOL® (PEG3350 plus electrolytes): 20 years of evidence‐based use. Key opinions in medicine, Gastroenterology, 3, 1
- 10.1002/j.1536-4801.2002.tb07654.x · DOI
- Bautista‐Casasnovas A, 2013, Polyethylene glycol with electrolytes in patients younger than 2 years old. Dosage, efficacy and tolerance. Study in 35 patients, Acta Pediatr Esp, 71, 213
Cited by
Gordon, M., de Geus, A., Boruta, M., Banasiuk, M., Benninga, M., Borrelli, O., Darbari, A., Dore‐Stites, D., Gould, M., Hawa, J., et al. (2026) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70447 · Cited by 4
Metadata
- Authors
- Roy, D., Akriche, F., Amlani, B., & Shakir, S.
- Affiliations
- Drug Safety Research Unit (GB)
- Norgine Global Medical Affairs Rueil Malmaison France
- Norgine (United Kingdom) (GB)
- Corresponding author
- Roy, Debabrata
- Shakir, Saad
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2021-02-10
- Volume
- 72
- Issue
- 5
- Pages
- 683-689
- ISSN
- 0277-2116 (ISSN-L)
- 1536-4801
- PMC
- PMC8549461
- OpenAlex
- W3129753646
- Cited by
- 10
- References
- 56
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 1
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Pediatric Gastroenterology and Nutrition (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Norgine
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- pediatric constipation, fecal impaction, infants under 2 years, drug safety, adverse events, electrolyte imbalance, real-world prescribing patterns, laxative use
- MeSH terms
- Child, Constipation, Electrolytes, Humans, Infant, Polyethylene Glycols, Retrospective Studies, Cohort Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
